04/05/2025
We publish what we practice! Rosacea is a frequent,underserved,chronic skin disease with a significant burden of disease. Despite relevant progress in its pathomechanistical understanding,which lead to innovative pharmacological drugs, its multifactorial nature makes it challenging to control. In real-world practice,we treat patients with rosacea with individulized programs,usually encompassing laser/IPL/BBL, tailored peelings (yes!-we peel rosacea!!), prescriptive topicals combined with bespoke OTC skincare regimen. In the last years, we have gained experience with the injection of low-cross-linked Hyaluronic Acid for improving skin quality. Along this journey (which included me literally traveling around the globe to train colleagues on this), we observed a significant anti-inflammatory, soothing effect of the injections on irritated, eczematous, sensitive and Rosacea affected facial skin,. Injection of „skin-boisters“( low-crosslinked Hyaluronic Acid) helps stabilizing and sustaining the results achieved by established treatment options. We decided that these Real-World-Data are worth reporting. I am very grateful for an amazing collaboration of international female dermatologists that lead to this important publication: Drssa Ilaria Poietti .ssa_ilaria_proietti from Rome,Italy and Dr Sadiye Kus .sadiyekus from Turkey together with me initiated this collection of reports.Thank you,Dr Michael Gold , editor of Journal of Cosmetic Dermatology for your support!
